About Lypro Bio
Welcome to a platform dedicated to innovative nanotechnology-based therapeutic delivery systems designed to improve the solubility, bioavailability, and biological performance of hydrophobic therapeutic compounds and other poorly soluble bioactive agents. Poor solubility and low bioavailability are common challenges in the development of effective treatments, often limiting clinical efficacy and increasing the risk of systemic side effects.
Our approach leverages the body’s natural mechanisms for transporting insoluble molecules, creating a biomimetic delivery strategy that allows hydrophobic compounds to circulate efficiently, reach their intended targets, and interact effectively with biological systems. This enables enhanced therapeutic outcomes while maintaining safety and stability under physiological conditions.
Self-Assembling Nanoscale Delivery Systems
The core of our technology is based on self-assembling, nanometer-scale bioparticles engineered to encapsulate hydrophobic therapeutic compounds into stable, water-soluble nanoscale structures.
These nanoscale assemblies are designed to :
Maintain structural integrity in aqueous and physiological environments
Facilitate targeted interaction with specific receptors or tissues
Protect bioactive compounds from premature degradation or inactivation
Protect bioactive compounds from premature degradation or inactivation
Nanoscale assemblies and their biomedical applications
"Nanoscale assemblies are a unique class of materials, which can be synthesized from inorganic, polymeric or biological building blocks. The multitude of applications of this class of materials ranges from solar and electrical to uses in food, cosmetics and medicine. In this review, we initially highlight characteristic features of polymeric nanoscale assemblies as well as those built from biological units (lipids, nucleic acids and proteins). We give special consideration to protein nanoassemblies found in nature such as ferritin protein cages, bacterial microcompartments and vaults found in eukaryotic cells and designed protein nanoassemblies, such as peptide nanofibres and peptide nanotubes. Next, we focus on biomedical applications of these nanoscale assemblies, such as cell targeting, drug delivery, bioimaging and vaccine development. In the vaccine development section, we report in more detail the use of virus-like particles and self-assembling polypeptide nanoparticles as new vaccine delivery platforms."
Enhanced Therapeutic Performance
Encapsulation of hydrophobic bioactive agents within self-assembling nanoscale structures provides multiple pharmacological advantages:
01
Increased therapeutic efficacy through enhanced delivery to target tissues
02
Reduced dosage requirements, minimizing systemic exposure
03
Lower incidence and severity of off-target effects
04
Improved pharmacokinetic profiles, supporting sustained and controlled therapeutic action
This biomimetic strategy supports:
Receptor-mediated targeting, improving tissue specificity
Efficient cellular uptake, enhancing intracellular delivery
Reduced degradation, extending the functional lifetime of the therapeutic agent
Applications in Nanomedicine and Biomedical Research
The technology is broadly applicable to hydrophobic therapeutic compounds, small molecules, and bioactive agents that face solubility or stability challenges. Its applications include:
Expertise and Knowledge
Customer satisfaction is our priority. Our support team is always ready to assist, ensuring you have a smooth and successful experience.
Eco-Friendly Solutions
We offer cutting-edge products and services to tackle modern challenges. Leveraging the latest technology, we help you achieve your goals.
Tailored Solutions
With extensive experience and deep industry knowledge, we provide insights and solutions that keep you ahead of the curve.
Our latest content
Check out what's new in our company !